✦ LIBER ✦
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin–cyclophosphamide versus carboplatin–cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study
✍ Scribed by David S. Alberts; Steve Dahlberg; Stephanie J. Green; Dava Garcia; Edward V. Hannigan; Robert O'toole; Donna Stock-Novack; Earl A. Surwit; Vinay K. Malviya; Christopher J. Jolles
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 888 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.